Transdermal buprenorphine - a critical appraisal of its role in pain management.
about
Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically activeSkin tolerability of transdermal patches.Advanced Analgesic Drug Delivery and Nanobiotechnology.Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica).A novel approach in the detoxification of intravenous buprenorphine dependence.Update on prescription extended-release opioids and appropriate patient selection.High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometryTopical preparations for pain relief: efficacy and patient adherence.Current options for providing sustained analgesia to laboratory animals.Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal painNanofibers used for the delivery of analgesics.Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.Safety and efficacy of transdermal buprenorphine versus oral tramadol for the treatment of post-operative pain following surgery for fracture neck of femur: A prospective, randomised clinical study.Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol/Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery.Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects.
P2860
Q24629014-D4FA504D-7566-4DF3-822B-43C77D964FA5Q30318415-75FE6DAB-557A-44DE-B918-EE20934653C4Q33845298-BDC51894-F5FB-4E26-B004-306B3CC51C91Q34620060-725ABC26-3019-409C-BEDC-072AF33BF18CQ37035679-DDFC38D8-91DB-499A-86E3-54BE0B5489A7Q37053718-BE9C817A-9100-4B04-A396-1D65D786F77EQ37606401-4430F5AB-B67E-4825-AA30-C72443B9AC5CQ37851017-84571B79-3747-4805-8DF7-8A0D00880C99Q38252634-B4EFE44D-EFF1-4BC4-BB60-70D8536DF151Q38400356-CDA3C2A0-7980-4D78-A3BC-12538FB47D88Q38529529-30864673-5300-408F-A3A6-F98FA522042FQ39206999-6E03B9A4-8D83-48C6-B3AB-8913DB1DE18BQ39234435-10B20040-5E19-48CB-9904-9EF7B955979AQ42293348-FC0AD3F3-A3C8-4EE6-B031-99DF39C61164Q43374980-3E3670C3-DF6E-4663-B384-964B9C397378Q51529259-AF4732CB-CB56-4FDD-909C-AB68C125ECB0
P2860
Transdermal buprenorphine - a critical appraisal of its role in pain management.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@ast
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@en
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@nl
type
label
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@ast
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@en
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@nl
prefLabel
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@ast
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@en
Transdermal buprenorphine - a critical appraisal of its role in pain management.
@nl
P2860
P356
P1476
Transdermal buprenorphine - a critical appraisal of its role in pain management
@en
P2093
Dominique Robert
P2860
P304
P356
10.2147/JPR.S6503
P50
P577
2009-09-15T00:00:00Z